Modelling genetic mosaicism of neurodevelopmental disorders in vivo by a Cre-amplifying fluorescent reporter.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 12 2020
Historique:
received: 29 01 2020
accepted: 27 10 2020
entrez: 4 12 2020
pubmed: 5 12 2020
medline: 17 12 2020
Statut: epublish

Résumé

Genetic mosaicism, a condition in which an organ includes cells with different genotypes, is frequently present in monogenic diseases of the central nervous system caused by the random inactivation of the X-chromosome, in the case of X-linked pathologies, or by somatic mutations affecting a subset of neurons. The comprehension of the mechanisms of these diseases and of the cell-autonomous effects of specific mutations requires the generation of sparse mosaic models, in which the genotype of each neuron is univocally identified by the expression of a fluorescent protein in vivo. Here, we show a dual-color reporter system that, when expressed in a floxed mouse line for a target gene, leads to the creation of mosaics with tunable degree. We demonstrate the generation of a knockout mosaic of the autism/epilepsy related gene PTEN in which the genotype of each neuron is reliably identified, and the neuronal phenotype is accurately characterized by two-photon microscopy.

Identifiants

pubmed: 33273479
doi: 10.1038/s41467-020-19864-w
pii: 10.1038/s41467-020-19864-w
pmc: PMC7713426
doi:

Substances chimiques

Fluorescent Dyes 0
Tamoxifen 094ZI81Y45
Cre recombinase EC 2.7.7.-
Integrases EC 2.7.7.-
PTEN Phosphohydrolase EC 3.1.3.67

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6194

Références

Nat Med. 2015 Apr;21(4):395-400
pubmed: 25799227
Brain. 2017 Oct 1;140(10):2610-2622
pubmed: 28969385
Neuron. 2012 Apr 12;74(1):41-8
pubmed: 22500628
Am J Hum Genet. 2000 Sep;67(3):574-81
pubmed: 10915612
Epilepsia. 2015 Nov;56(11):1669-86
pubmed: 26434565
Epilepsia. 2016 Mar;57(3):e51-5
pubmed: 26765483
Trends Genet. 2018 May;34(5):333-340
pubmed: 29336844
J Neurosci. 2019 Apr 3;39(14):2762-2773
pubmed: 30700531
Nat Commun. 2019 May 22;10(1):2262
pubmed: 31118412
Nature. 2000 Apr 20;404(6780):876-81
pubmed: 10786794
Nat Med. 2015 Dec;21(12):1445-54
pubmed: 26523971
Biomed Opt Express. 2016 Mar 30;7(4):1604-13
pubmed: 27446677
Nat Neurosci. 2017 Sep;20(9):1217-1224
pubmed: 28714951
Ann Neurol. 1995 Apr;37(4):476-87
pubmed: 7717684
Am J Hum Genet. 2017 Sep 7;101(3):369-390
pubmed: 28867142
Biochemistry. 2003 Jul 8;42(26):7879-84
pubmed: 12834339
Epilepsy Res. 2015 Jul;113:132-9
pubmed: 25986200
J Neurosci. 2011 Mar 16;31(11):4345-54
pubmed: 21411674
Elife. 2017 May 16;6:
pubmed: 28509666
Development. 2011 Dec;138(23):5049-55
pubmed: 22069183
Nat Commun. 2016 Jun 01;7:11753
pubmed: 27249187
Brain. 2000 Aug;123 ( Pt 8):1733-51
pubmed: 10908202
Dis Model Mech. 2009 Jul-Aug;2(7-8):389-98
pubmed: 19470613
Nat Rev Neurol. 2011 Jul 05;7(8):439-50
pubmed: 21727940
Genesis. 2013 Jun;51(6):436-42
pubmed: 23441020
Sci Rep. 2017 Jan 10;7:40054
pubmed: 28071688
Nat Methods. 2018 Dec;15(12):1033-1036
pubmed: 30455464
Nat Genet. 2012 Jun 24;44(8):941-5
pubmed: 22729223
BMC Med Genet. 2014 Feb 27;15:26
pubmed: 24580998
Dev Neurosci. 2008;30(1-3):59-64
pubmed: 18075255
Cell Rep. 2012 Aug 30;2(2):386-96
pubmed: 22884371
Epilepsia. 2011 Jan;52(1):158-74
pubmed: 21219302
Nat Rev Genet. 2013 May;14(5):307-20
pubmed: 23594909
Development. 2015 Oct 15;142(20):3601-11
pubmed: 26400094
Brain. 2015 Jun;138(Pt 6):1613-28
pubmed: 25722288
Nat Genet. 2008 Jun;40(6):776-81
pubmed: 18469813
Mol Psychiatry. 2019 Nov;24(11):1627-1640
pubmed: 30967683
BMC Med Genet. 2018 Jun 4;19(1):92
pubmed: 29866057
Genesis. 2002 Nov;34(3):208-14
pubmed: 12395386
Nat Genet. 2001 Dec;29(4):404-11
pubmed: 11726927
Front Mol Neurosci. 2014 Apr 01;7:23
pubmed: 24744697
Sci Rep. 2011;1:45
pubmed: 22355564
Nat Commun. 2012 Jul 17;3:960
pubmed: 22805567
Neuron. 2012 Sep 20;75(6):1022-34
pubmed: 22998871
PLoS Genet. 2009 Feb;5(2):e1000381
pubmed: 19214208
PLoS Genet. 2016 Sep 15;12(9):e1006245
pubmed: 27632392
Nat Genet. 2001 Dec;29(4):396-403
pubmed: 11726926
Nat Rev Genet. 2017 Feb;18(2):128-142
pubmed: 27941868
Mol Syndromol. 2016 Sep;7(4):220-233
pubmed: 27781032
Cell. 2019 Sep 19;179(1):251-267.e24
pubmed: 31539496
Sci Rep. 2018 Apr 12;8(1):5913
pubmed: 29651133
Nat Commun. 2019 Nov 19;10(1):5224
pubmed: 31745093
Nat Protoc. 2016 Mar;11(3):399-412
pubmed: 26844428
Front Neural Circuits. 2012 Jul 27;6:47
pubmed: 22866029
Neurology. 2003 Oct 28;61(8):1042-6
pubmed: 14581661
J Vis Exp. 2013 Feb 11;(72):
pubmed: 23426329
Trends Neurosci. 2010 Feb;33(2):67-75
pubmed: 19963289
Nat Neurosci. 2018 Nov;21(11):1504-1514
pubmed: 30349109
J Neurosci. 2015 Jan 21;35(3):943-59
pubmed: 25609613
Cell. 2017 Aug 10;170(4):800-814.e18
pubmed: 28802047
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1027-32
pubmed: 17209010
Nat Biotechnol. 2003 May;21(5):562-5
pubmed: 12665802
Hum Mutat. 2017 Aug;38(8):1002-1013
pubmed: 28503910
N Engl J Med. 2014 Aug 21;371(8):733-43
pubmed: 25140959
Brain Res. 2007 Sep 7;1168:112-23
pubmed: 17706614
Neuron. 2013 Jun 5;78(5):773-84
pubmed: 23764283
J Vis Exp. 2017 Nov 17;(129):
pubmed: 29286375
Brain. 2004 Nov;127(Pt 11):2406-18
pubmed: 15319274

Auteurs

Francesco Trovato (F)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy. francesco.trovato@sns.it.

Riccardo Parra (R)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Enrico Pracucci (E)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Silvia Landi (S)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.
Institute of Neuroscience CNR, Pisa, Italy.

Olga Cozzolino (O)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Gabriele Nardi (G)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Federica Cruciani (F)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Vinoshene Pillai (V)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Laura Mosti (L)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy.

Andrzej W Cwetsch (AW)

Istituto Italiano di Tecnologia, Genoa, Italy.
Università degli studi di Genova, Genoa, Italy.

Laura Cancedda (L)

Istituto Italiano di Tecnologia, Genoa, Italy.
Istituto Telethon Dulbecco, Rome, Italy.

Laura Gritti (L)

Institute of Neuroscience CNR, Milan, Italy.

Carlo Sala (C)

Institute of Neuroscience CNR, Milan, Italy.

Chiara Verpelli (C)

Institute of Neuroscience CNR, Milan, Italy.

Andrea Maset (A)

Veneto Institute of Molecular Medicine, Padua, Italy.
Padova Neuroscience Center, Padova Università di Padova, Padua, Italy.

Claudia Lodovichi (C)

Veneto Institute of Molecular Medicine, Padua, Italy.
Padova Neuroscience Center, Padova Università di Padova, Padua, Italy.
Institute of Neuroscience CNR, Padua, Italy.

Gian Michele Ratto (GM)

National Enterprise for Nanoscience and Nanotechnology (NEST), Istituto Nanoscienze Consiglio Nazionale delle Ricerche (CNR) and Scuola Normale Superiore Pisa, 56127, Pisa, Italy. gianmichele.ratto@sns.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH